Paper3894793
Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.
Sibley RK and 3 others. Lab Invest, 1985. Cited by 387 papers, by iCite.
Cite this record
ConductScience Library. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Papers, record 3894793. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3894793
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Pancreas Transplantation | Major topic |
| Adult | |
| Antibodies, Monoclonal | |
| Diseases in Twins | |
| Female | |
| HLA-DR Antigens | |
| Histocompatibility Antigens Class II | |
| Humans | |
| Immunity, Cellular | |
| Immunochemistry | |
| Islets of Langerhans | |
| Microscopy, Electron | |
| Pancreas | |
| Recurrence | |
| Transplantation, Homologous | |
| Transplantation, Isogeneic |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI 10704 | NIAID NIH HHS | United States | R01AI010704 | PubMed and NIH | NIH RePORTER |
| AM 13083 | NIADDK NIH HHS | United States | P01AM013083 | PubMed and NIH | NIH RePORTER |
| AM 25518 | NIADDK NIH HHS | United States | R01AM025518 | PubMed and NIH | NIH RePORTER |
| P02AM013083 | NIH | NIH RePORTER | |||
| R37AI010704 | NIH | NIH RePORTER |
Cited by103
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 387 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39658052 | Lymph nodes as gatekeepers of autoimmune diseases. | RMD Open | 2024 | https://conductscience.org/library/papers/39658052 | PubMed |
| 39346923 | Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation. | Front Immunol | 2024 | https://conductscience.org/library/papers/39346923 | PubMed |
| 36545154 | Genetic Engineering of Immune Evasive Stem Cell-Derived Islets. | Transpl Int | 2022 | https://conductscience.org/library/papers/36545154 | PubMed |
| 35418988 | The Influence of Microenvironment on Survival of Intraportal Transplanted Islets. | Front Immunol | 2022 | https://conductscience.org/library/papers/35418988 | PubMed |
| 35163121 | Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163121 | PubMed |
| 34102338 | Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes. | Acta Biomater | 2021 | https://conductscience.org/library/papers/34102338 | PubMed |
| 34067829 | Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34067829 | PubMed |
| 33918805 | Islet Dysfunction in a Novel Transgenic Model of T Cell Insulitis. | Biomolecules | 2021 | https://conductscience.org/library/papers/33918805 | PubMed |
| 33293704 | Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?). | Nat Rev Endocrinol | 2021 | https://conductscience.org/library/papers/33293704 | PubMed |
| 32668238 | Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells. | Cell Rep | 2020 | https://conductscience.org/library/papers/32668238 | PubMed |
| 31767825 | Autoimmune Diabetes Recurrence After Pancreas Transplantation: Diagnosis, Management, and Literature Review. | Ann Transplant | 2019 | https://conductscience.org/library/papers/31767825 | PubMed |
| 30541144 | Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions. | Endocr Rev | 2019 | https://conductscience.org/library/papers/30541144 | PubMed |
| 29196783 | Combinatorial detection of autoreactive CD8+ T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell Workshop. | Diabetologia | 2018 | https://conductscience.org/library/papers/29196783 | PubMed |
| 28864875 | Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime". | Curr Diab Rep | 2017 | https://conductscience.org/library/papers/28864875 | PubMed |
| 28099204 | Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'. | Curr Opin Endocrinol Diabetes Obes | 2017 | https://conductscience.org/library/papers/28099204 | PubMed |
| 27798614 | Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. | Nat Med | 2016 | https://conductscience.org/library/papers/27798614 | PubMed |
| 27348473 | Biomarkers in pancreas transplant. | Curr Opin Organ Transplant | 2016 | https://conductscience.org/library/papers/27348473 | PubMed |
| 27110598 | Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir? | Immunotherapy (Los Angel) | 2015 | https://conductscience.org/library/papers/27110598 | PubMed |
| 27063289 | A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells. | Nat Commun | 2016 | https://conductscience.org/library/papers/27063289 | PubMed |
| 26970668 | Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation. | Transplant Rev (Orlando) | 2016 | https://conductscience.org/library/papers/26970668 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD2 | 914 | PubTator's text mining | https://conductscience.org/library/genes/914 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| TFRC | 7037 | PubTator's text mining | https://conductscience.org/library/genes/7037 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3894793
GET https://conductscience.org/api/papers/v1/3894793/cited_by?page=2